[1] |
Jemal A, Bray F, Center MM, et al.Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
[2] |
Center MM, Jemal A, Ward E.International trends in colorectal cancer incidence rates[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(6):1688-1694.
|
[3] |
Bufill JA.Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location[J]. Ann Intern Med, 1990, 113(10):779-788.
|
[4] |
Brule SY, Jonker DJ, Karapetis CS, et al.Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17[J]. European Journal of Cancer, 2015, 51(11):1405-1414.
|
[5] |
Iacopetta B.Are there two sides to colorectal cancer?[J]. Int J Cancer, 2002, 101(5):403-408.
|
[6] |
Jess P, Hansen IO, Gamborg M, et al.A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer[J]. BMJ Open, 2013, 3(5):pii:e002608.
|
[7] |
Ishihara S, Nishikawa T, Tanaka T, et al.Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study[J]. Int J Surg, 2014, 12(9):925-930.
|
[8] |
Benedix F, Meyer F, Kube R, et al. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma[J]. Pathol Res Pract, 2012 , 208(10):592-597.
|
[9] |
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. N Engl J Med, 2004, 350(23):2335–2342.
|
[10] |
Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer - a systematic review[J]. Danish Medical Journal, 2012, 59(6):A4444.
|
[11] |
Clark S.Outcome of right - and left-sided colonic and rectal cancer following surgical resection[J]. Colorectal Dis, 2012, 14(3):386.
|
[12] |
Christodoulidis G, Spyridakis M, Symeonidis D, et al.Clinicopathological differences between right - and left-sided colonic tumors and impact upon survival[J]. Techniques in coloproctology, 2010, 14(Suppl 1):S45-47.
|
[13] |
Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right - and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival[J]. Dis Colon Rectum, 2010 , 53(1):57-64.
|
[14] |
Cassidy J, Clarke S, Díaz-Rubio E, et al. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results[J]. Br J Cancer, 2011, 105(1):58–64.
|
[15] |
Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study[J]. J Clin Oncol, 2008,26(12):2013–2019.
|
[16] |
Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right - and left - sided colon cancer: a 17-year experience at a single institution[J]. Surgery today, 2014, 44(9):1685-1691.
|
[17] |
Huang CW, Tsai HL, Huang MY, et al. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer[J]. World J Surg Oncol, 2015, 13:257.
|
[18] |
Nitsche U, Stögbauer F, Späth C, et al. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis[J]. Digestive Surgery, 2016, 33(2):157-163.
|
[19] |
von Einem JC, Heinemann V, von Weikersthal LF, et al.Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial[J]. J Cancer Res Clin Oncol, 2014, 140(9):1607-1614.
|
[20] |
He WZ, Xia LP. RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer[J]. J Natl Cancer Inst, 2015, 107(9).
|
[21] |
Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right - versus left-sided colon cancers?[J]. Ann Surg Oncol, 2008, 15(9):2388-2394.
|
[22] |
Weiss JM, Pfau PR, O'Connor ES, et al.Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data[J]. J Clin Oncol, 2011, 29(33):4401-4409.
|